Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump
Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump Reuters
Lean: Center
Fact-focusedFactuality: Very highCountry: United KingdomFunding: CorporateOwner: Thomson Reuters
CNBC Eli Lilly CEO on affordable access to obesity drugs for seniors
Eli Lilly CEO Dave Ricks talks with CNBC about working with the Trump administration to provide obesity drugs at lower costs for seniors. The company on Thursday reported third-quarter earnings and revenue that blew...
Lean: Center VideoFactuality: HighCountry: United StatesFunding: Corporate
Coverage breakdown
Funding
Corporate
Countries
United States
United Kingdom
Media ownership
CNBC
Thomson Reuters
Avg reliability86
Low-credibility share0%
Fact / opinion3/0
State media0%
More analysis
Trending: Low
Sources: 2
Reliability: 86
Bias severity: 0
Risk: 0Sentiment: -33Sensationalism: 0
Amplification: 0